Skip to content

Commit dcf4a61

Browse files
swissclockclaude
andcommitted
Reframe the opening line and link Modulight Bio from the Now section
The thesis now reads "Now I help build a platform to fix it", which is both what he actually does and a cleaner pairing with "breaks" than the light metaphor was. Modulight Bio in the Now section is a link to modulight.bio, so a reader can go and read about the company. Running text had no link style of its own, since the global rule strips underlines, so inline links now sit on a baseline rule that takes the state colour on hover and focus. Co-Authored-By: Claude Opus 5 <noreply@anthropic.com>
1 parent 2a93b95 commit dcf4a61

2 files changed

Lines changed: 11 additions & 2 deletions

File tree

‎src/content/data.js‎

Lines changed: 2 additions & 2 deletions
Original file line numberDiff line numberDiff line change
@@ -14,7 +14,7 @@ export const person = {
1414
role: 'Neuroscientist',
1515
location: 'Israel',
1616
// The one-sentence thesis of the whole site.
17-
thesis: 'I spent a decade learning how the brain <em>breaks</em>. Now I build the light that <em>quiets</em> it.',
17+
thesis: 'I spent a decade learning how the brain <em>breaks</em>. Now I help build a platform to <em>fix</em> it.',
1818
affiliations: [
1919
{ what: 'Director of In-vivo Research', where: 'Modulight Bio' },
2020
{ what: 'Research Associate', where: 'Weizmann Institute' },
@@ -32,7 +32,7 @@ export const meta = {
3232
export const now = {
3333
heading: 'Turning a receptor into a <em>dimmer switch</em>',
3434
paragraphs: [
35-
'At Modulight Bio I direct in-vivo research on an optogenetic therapy. The platform uses <b>optoGPCRs</b>: light-activated G protein-coupled receptors delivered to the nerves that carry pain. Our workhorse is <b>eOPN3</b>, a rhodopsin borrowed from mosquitoes that recruits the Gi/o cascade and suppresses neurotransmitter release at the presynaptic terminal.',
35+
'At <a href="https://modulight.bio" target="_blank" rel="noopener">Modulight Bio</a> I direct in-vivo research on an optogenetic therapy. The platform uses <b>optoGPCRs</b>: light-activated G protein-coupled receptors delivered to the nerves that carry pain. Our workhorse is <b>eOPN3</b>, a rhodopsin borrowed from mosquitoes that recruits the Gi/o cascade and suppresses neurotransmitter release at the presynaptic terminal.',
3636
'It does not force a neuron to fire, and it does not clamp it silent. It turns down what that terminal releases, and then lets it come back on its own. The first indication we are taking towards the clinic is <em>trigeminal neuropathic pain</em>, where the nerve is reachable enough for light to do the work.'
3737
],
3838
// Explains the interactive control without instructing the reader like a manual.

‎src/styles/base.css‎

Lines changed: 9 additions & 0 deletions
Original file line numberDiff line numberDiff line change
@@ -104,6 +104,15 @@ p + p { margin-top: 1.1em; }
104104
max-width: 58ch;
105105
}
106106
.body em { font-style: italic; color: var(--ink); }
107+
/* A link inside running text. It sits on the baseline rule rather than taking
108+
the accent outright, so prose does not turn into a row of buttons. */
109+
.body a {
110+
color: var(--ink);
111+
border-bottom: 1px solid var(--ink-4);
112+
transition: color var(--t-fast) var(--ease), border-color var(--t-fast) var(--ease);
113+
}
114+
.body a:hover,
115+
.body a:focus-visible { border-color: var(--accent); }
107116
.body b { font-weight: 400; color: var(--ink); }
108117

109118
/* The one paragraph set in mono, because it describes the instrument. */

0 commit comments

Comments
 (0)